Sepsis is characterised by a dysregulated host immune response to infection. Despite recognition of its significance, immune status monitoring is not implemented in clinical practice due in part to the current absence of direct therapeutic implications. Technological advances in immunological profiling could enhance our understanding of immune dysregulation and facilitate integration into clinical practice. In this Review, we provide an overview of the current state of immune profiling in sepsis, including its use, current challenges, and opportunities for progress. We highlight the important role of immunological biomarkers in facilitating predictive enrichment in current and future treatment scenarios. We propose that multiple immune and non-immune-related parameters, including clinical and microbiological data, be integrated into diagnostic and predictive combitypes, with the aid of machine learning and artificial intelligence techniques. These combitypes could form the basis of workable algorithms to guide clinical decisions that make precision medicine in sepsis a reality and improve patient outcomes.

Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine / Cajander, S; Kox, M; Scicluna, Bp; Weigand, Ma; Mora, Ra; Flohé, Sb; Martin-Loeches, I; Lachmann, G; Girardis, M; Garcia-Salido, A; Brunkhorst, Fm; Bauer, M; Torres, A; Cossarizza, A; Monneret, G; Cavaillon, J-M; Shankar-Hari, M; Giamarellos-Bourboulis, Ej; Winkler, Ms; Skirecki, T; Osuchowski, M; Rubio, I; Bermejo-Martin, Jf; Schefold, Jc; Venet, F.. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - 12:4(2024), pp. 305-322. [10.1016/S2213-2600(23)00330-2]

Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

Girardis M;Cossarizza A;
2024

Abstract

Sepsis is characterised by a dysregulated host immune response to infection. Despite recognition of its significance, immune status monitoring is not implemented in clinical practice due in part to the current absence of direct therapeutic implications. Technological advances in immunological profiling could enhance our understanding of immune dysregulation and facilitate integration into clinical practice. In this Review, we provide an overview of the current state of immune profiling in sepsis, including its use, current challenges, and opportunities for progress. We highlight the important role of immunological biomarkers in facilitating predictive enrichment in current and future treatment scenarios. We propose that multiple immune and non-immune-related parameters, including clinical and microbiological data, be integrated into diagnostic and predictive combitypes, with the aid of machine learning and artificial intelligence techniques. These combitypes could form the basis of workable algorithms to guide clinical decisions that make precision medicine in sepsis a reality and improve patient outcomes.
2024
12
4
305
322
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine / Cajander, S; Kox, M; Scicluna, Bp; Weigand, Ma; Mora, Ra; Flohé, Sb; Martin-Loeches, I; Lachmann, G; Girardis, M; Garcia-Salido, A; Brunkhorst, Fm; Bauer, M; Torres, A; Cossarizza, A; Monneret, G; Cavaillon, J-M; Shankar-Hari, M; Giamarellos-Bourboulis, Ej; Winkler, Ms; Skirecki, T; Osuchowski, M; Rubio, I; Bermejo-Martin, Jf; Schefold, Jc; Venet, F.. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - 12:4(2024), pp. 305-322. [10.1016/S2213-2600(23)00330-2]
Cajander, S; Kox, M; Scicluna, Bp; Weigand, Ma; Mora, Ra; Flohé, Sb; Martin-Loeches, I; Lachmann, G; Girardis, M; Garcia-Salido, A; Brunkhorst, Fm; B...espandi
File in questo prodotto:
File Dimensione Formato  
2024 Lancet Resp Med - Cajander.pdf

Accesso riservato

Tipologia: VOR - Versione pubblicata dall'editore
Dimensione 608.89 kB
Formato Adobe PDF
608.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1372386
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 37
social impact